US Budget Stopgap, FDA User Fee Reauthorization On Tap Minus Supplement MPL Program

With current user fee package as well all federal spending programs for FY2022 expiring on 30 September, House and Senate committee leaders reach agreement on FDA user fee reauthorization included in a continuing resolution to extend federal spending at current levels through 16 December.

Requiring registration with the Food and Drug Administration for all dietary supplements sold in the US has to wait for a chance at approval through legislation other than provisions added to a bill reauthorizing the agency’s drug and medical device user fee programs.

The current user fee package, along with all federal spending programs for fiscal year 2022, will expire on 30 September....